Search for new treatment methods for metabolic/blood/endocrine diseases, and Alzheimer’s Disease

Diabetes and dyslipidemia lead to various fatal diseases, and are also gaining attention as a primary factor for the worsening of the prognosis of other complications. Recently, there has been a heavy emphasis on not just treating these diseases, but controlling the pathology by early intervention. In our laboratory, we will clarify the pathology and consider control and treatment at the genetic level, as we aim to construct new theories. Additionally, as clinical data demonstrating the relationship between these metabolic/endocrine diseases and Alzheimer’s Disease is becoming known, we will explore new approaches in these fields, and develop clinical research.